Molecular analysis of Thymoma

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Badve, Sunil ^a,b   Goswami, Chirayu ^a   Gökmen Polar, Yesim ^a   Nelson, Robert P ^a   Henley, John ^c   Miller, Nick ^a   Zaheer, Narjis A ^a   Sledge, George W ^a,b   Li, Lang ^a   Kesler, Kenneth A ^a   Loehrer, Patrick J ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Pain Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH RECEPTOR;

ADOLESCENT; AGED; AMINO ACID METABOLISM; ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIPOGENESIS; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; STEROIDOGENESIS; THYMOMA;

EID: 84865058587     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042669     Document Type: Article

References (25)

1. Fornasiero A, Daniele O, Ghiotto C, Sartori F, Rea F, et al. (1990) Chemotherapy of invasive thymoma. J Clin Oncol 8: 1419-1423.
2. Engels EA, Pfeiffer RM, (2003) Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 105: 546-551.
3. Lattes R, (1962) Thymoma and other tumors of the thymus. An analysis of 107 cases. Cancer 15: 1224-1260.
4. Casey EM, Kiel PJ, Loehrer PJ Sr, (2008) Clinical management of thymoma patients. Hematol Oncol Clin North Am 22: 457-473.
5. Jain RK, Mehta RJ, Henley JD, Kesler KA, Loehrer PJ, et al. (2010) WHO types A and AB thymomas: not always benign. Mod Pathol 23: 1641-1649.
6. Okereke IC, Kesler KA, Morad MH, Mi D, Rieger KM, et al. (2010) Prognostic indicators after surgery for thymoma. Ann Thorac Surg 89: 1071-1077 discussion 1077-1079.
7. Rosai J, Sobin LH (1999) Histological typing of tumours of the thymus. Berlin; New York: Springer. x, 65 p.
8. Travis WD, World Health Organization., International Agency for Research on Cancer., International Association for the Study of Lung Cancer., International Academy of Pathology. (2004) Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon Oxford: IARC Press Oxford University Press (distributor). 344 p.
9. Masaoka A, Monden Y, Nakahara K, Tanioka T, (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48: 2485-2492.
10. Granato F, Ambrosio MR, Spina D, Lazzi S, Rocca BJ, et al. (2012) Patients with thymomas have an increased risk of developing additional malignancies: lack of immunological surveillance? Histopathology 60: 437-442.
11. Thomas CR, Wright CD, Loehrer PJ, (1999) Thymoma: state of the art. J Clin Oncol 17: 2280-2289.
12. Sasaki H, Ide N, Fukai I, Kiriyama M, Yamakawa Y, et al. (2002) Gene expression analysis of human thymoma correlates with tumor stage. Int J Cancer 101: 342-347.
13. Lee GY, Yang WI, Jeung HC, Kim SC, Seo MY, et al. (2007) Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization. BMC Genomics 8: 305.
14. Girard N, Shen R, Guo T, Zakowski MF, Heguy A, et al. (2009) Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Clin Cancer Res 15: 6790-6799.
15. Kristoffersson U, Heim S, Mandahl N, Akerman M, Mitelman F, (1989) Multiple clonal chromosome aberrations in two thymomas. Cancer Genet Cytogenet 41: 93-98.
16. Dal Cin P, De Wolf-Peeters C, Aly MS, Deneffe G, Van Mieghem W, et al. (1993) Ring chromosome 6 as the only change in a thymoma. Genes Chromosomes Cancer 6: 243-244.
17. Inoue M, Starostik P, Zettl A, Strobel P, Schwarz S, et al. (2003) Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas. Cancer Res 63: 3708-3715.
18. Fukumoto S, Yamauchi N, Moriguchi H, Hippo Y, Watanabe A, et al. (2005) Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas. Clin Cancer Res 11: 1776-1785.
19. Chung YT, Matkowskyj KA, Li H, Bai H, Zhang W, et al. (2012) Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma. Mod Pathol.
20. Heringlake S, Hofdmann M, Fiebeler A, Manns MP, Schmiegel W, et al. (2010) Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours. J Hepatol 52: 220-227.
21. Yoshitake H, Takahashi M, Ishikawa H, Nojima M, Iwanari H, et al. (2007) Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer. Int J Gynecol Cancer 17: 1300-1306.
22. Ma J, Yan R, Zu X, Cheng JM, Rao K, et al. (2008) Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells. J Biol Chem 283: 3418-3423.
23. Liu J, Wen G, Cao D, (2009) Aldo-keto reductase family 1 member B1 inhibitors: old drugs with new perspectives. Recent Pat Anticancer Drug Discov 4: 246-253.
24. Chong IW, Chang MY, Chang HC, Yu YP, Sheu CC, et al. (2006) Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer. Oncol Rep 16: 981-988.
25. Wei JS, Greer BT, Westermann F, Steinberg SM, Son CG, et al. (2004) Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma. Cancer Res 64: 6883-6891.